SEC 8-K: Item 5.07
Official SEC filing update. Items: 5.07.
Loading...
Explore comprehensive financial data for Colgate-Palmolive, provided completely free. Analyze revenue, net income, profit margins, dividend history, and key financial ratios to make informed investment decisions.
Data as of (571 days ago)|Source: SEC EDGAR
The information on this page is for informational purposes only and does not constitute investment advice, financial advice, or any recommendation. Billiver does not recommend buying, selling, or holding any security. Past performance is not indicative of future results.
Data may be delayed and accuracy is not guaranteed. All investment decisions are solely your responsibility. Verify information independently and consult a qualified financial advisor before investing. About · Methodology
Colgate-Palmolive (CL) is a household products company. The company reports annual revenue of $20.1B and net income of $2.9B. Its profit margin is 14.5%.
Data from SEC EDGAR filings. TTM = Trailing Twelve Months.
Below average; significant concerns in multiple areas
-3 pts YoYThis Financial Health Score is a proprietary metric calculated from SEC EDGAR filings for educational and informational purposes only. It does not constitute investment advice or a recommendation to buy or sell any security. Results vary significantly by industry. Conduct your own research before making investment decisions.
Data sourced from SEC EDGAR filings. Not investment advice.
Official filing updates from SEC EDGAR. Billiver stores internal evidence snapshots for verification, but this page links to the SEC source instead of republishing full filing text.
Official SEC filing update. Items: 5.07.
Official SEC filing update.
Official SEC filing update. Items: 2.02, 2.05, 9.01.
Official SEC filing update. Items: 5.02.
Official SEC filing update.
Source: SEC EDGAR · 5 filings
Informational only. Not investment advice.
Source: SEC EDGAR 8-K Filings
Chart shows fiscal year data from SEC EDGAR filings. Hover over data points for details.
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.
Price-based valuation metrics (P/E, P/B) require real-time stock price data which is not included in SEC filings.
Benjamin Graham: Graham recommended P/E ratio not exceed 15 for reasonable valuation. Understanding valuation metrics
vs 10.7% sector median / 9.8% avg
Keeps 14 cents of every dollar in revenue as profit. Higher than 80% in Consumer Staples.
9th consecutive year of revenue growth.
* Some quarterly data is missing. Values are calculated based on annual report figures.
Profit margin 47% above sector average.
Warren Buffett: Buffett looks for consistent ROE above 20% as a sign of competitive advantage. How to evaluate profitability
vs 0.75 sector median / 3.27 avg
Carries $8.54 in debt for every $1 of equity. Lower debt than 33% in Consumer Staples.
Debt-to-equity ratio of 8.54 is above 1.5.
Peter Lynch: Lynch: normal balance sheet has 75% equity, 25% debt. Understanding financial health
Dividend yield data is not available from SEC filings. Check the company's investor relations page for dividend information.
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $20.4B(+1.4%) | $20.1B(+3.3%) | $19.5B(+8.3%) | $18.0B(+3.1%) | $17.4B(+5.8%) | $16.5B(+5.0%) | $15.7B(+1.0%) | $15.5B(+0.6%) | $15.5B(+1.7%) | $15.2B(-5.2%) |
| Net Income | $2.1B(-26.2%) | $2.9B(+25.6%) | $2.3B(+28.9%) | $1.8B(-17.6%) | $2.2B(-19.6%) | $2.7B(+13.9%) | $2.4B(-1.4%) | $2.4B(+18.6%) | $2.0B(-17.1%) | $2.4B(+76.4%) |
| Total Assets | $16.3B | $16.0B | $16.4B | $15.7B | $15.0B | $15.9B | $15.0B | $12.2B | $12.7B | $12.1B |
| Total Debt | $7.8B | $7.0B | $8.2B | $8.7B | $7.2B | $7.3B | $7.3B | $6.4B | $6.6B | $6.5B |
| Total Equity | $54.0M | $212.0M | $609.0M | $401.0M | $609.0M | $743.0M | $117.0M | $-102,000,000 | $-60,000,000 | $-243,000,000 |
| Profit Margin | 10.5% | 14.4% | 11.8% | 9.9% | 12.4% | 16.4% | 15.1% | 15.4% | 13.1% | 16.1% |
| ROE | 3948.1% | 1362.7% | 377.7% | 445.1% | 355.7% | 362.7% | 2023.1% | - | - | - |
| ROA | 13.1% | 18.0% | 14.0% | 11.3% | 14.4% | 16.9% | 15.7% | 19.7% | 16.0% | 20.1% |
| Metric | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $4.9B | $15.2B | $10.1B | $5.1B | $14.5B | $9.6B | $4.8B | $13.3B |
| Net Income | $690.0M | $2.1B | $1.4B | $683.0M | $1.6B | $874.0M | $372.0M | $1.8B |
| Total Assets | $16.3B | $16.0B | $16.0B | $16.0B | $16.4B | $16.4B | $16.4B | $15.7B |
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
7 insiders sold shares worth $25.1M, despite revenue growth of +1.4% YoY. Divergence signal strength: 40/100.
Source: SEC EDGAR Form 4 filings. Only purchase (P) and sale (S) transactions shown.
This company pays dividends. Historical dividend data shown below.
5-year dividend CAGR: -2.3%.
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend/Share | $1.55 | $1.59 | $1.66 | $1.71 | $1.75 | $1.79 | $1.86 | $1.91 | $2.48 | $1.56 |
| YoY Growth | +3.3% | +2.6% | +4.4% | +3.0% | +2.3% | +2.3% | +3.9% | +2.7% | +29.8% | -37.1% |
| Payments | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 |
| Increased | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | Yes | No |
Learn more: Dividend investing guide | How to evaluate dividend safety
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
Generates approximately $10M in free cash flow per day.
| Metric | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating CF | $3.1B | $3.1B | $3.1B | $3.1B | $3.7B | $3.3B | $2.6B | $3.7B | $4.1B | $4.2B |
| CapEx | -$593.0M | -$553.0M | -$436.0M | -$335.0M | -$409.0M | -$567.0M | -$696.0M | -$705.0M | -$561.0M | -$564.0M |
| Free Cash Flow | $2.5B | $2.5B | $2.6B | $2.8B | $3.3B | $2.8B | $1.9B | $3.0B | $3.5B | $3.6B |
| FCF Margin | 16.8% | 16.2% | 16.9% | 17.8% | 20.1% | 15.8% | 10.3% | 15.6% | 17.6% | 17.8% |
Source: SEC EDGAR 10-K filings. FCF = Operating Cash Flow - Capital Expenditures. Free cash flow guide
As of FY2025 · SEC 10-K · Updated Jul 4, 2026
Company-disclosed SEC risk factors
Risk factors are disclosed by the company in its SEC Form 10-K, Item 1A. Billiver does not classify or summarize company-specific legal, operational, financial, or market risks here.
Sector context: Consumer Staples. This is not a Billiver risk assessment for CL.
Source note: the SEC Form 10-K includes Item 1A, "Risk Factors." The full risk-factor text should be read from the company’s own SEC filing.
Colgate-Palmolive (CL) reported $20.1 billion in trailing twelve-month (TTM) revenue. This financial data is compiled from SEC EDGAR 10-K filings.
Yes, Colgate-Palmolive is profitable with a 14.5% net profit margin and $2.9 billion in net income (TTM). All figures from SEC EDGAR 10-K filings.
Yes, Colgate-Palmolive pays regular dividends. View the full dividend history and payout analysis on this page.
Colgate-Palmolive has a financial health score of 57/100 (Grade: D), evaluating profitability, solvency, liquidity, and growth based on SEC EDGAR data.
10 years of financial data are available for Colgate-Palmolive from FY2016 to FY2025. All figures are compiled from SEC EDGAR 10-K filings.